CATX vs MSFT: Which Stock is Better?
Side-by-side comparison of Perspective Therapeutics Inc and Microsoft Corp in 2026
CATX
Perspective Therapeutics Inc
$2.43
MSFT
Microsoft Corp
$454.79
Key Metrics Comparison
| Metric | CATX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $173.21M | $3.38T | MSFT |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | -0.4% | 14.9% | MSFT |
| Gross Margin | -5664.2% | 68.8% | MSFT |
Analyze CATX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CATX or MSFT a better investment?
Comparing CATX and MSFT: Perspective Therapeutics Inc has a market cap of $173.21M while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CATX and MSFT?
CATX (Perspective Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CATX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CATX or MSFT?
MSFT has higher revenue growth at 14.9% vs -0.4% for CATX.
Which company is more profitable: CATX or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to -5664.2% for CATX.
Which is the larger company: CATX or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $173.21M for CATX.
Should I buy CATX or MSFT in 2026?
Both CATX and MSFT have investment merit. CATX trades at $2.43 while MSFT trades at $454.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CATX and MSFT stock?
Key differences: Market Cap ($173.21M vs $3.38T), P/E Ratio (N/A vs 36.3x), Revenue Growth (-0.4% vs 14.9%), Gross Margin (-5664.2% vs 68.8%).